Related Experiment Video
Updated: Apr 17, 2026

Gastrointestinal Motility Monitor GIMM
Published on: December 1, 2010
Prokinetics in gastroparesis
Andres Acosta1, Michael Camilleri1
1Clinical Enteric Neuroscience Translational and Epidemiological Research (C.E.N.T.E.R.), Mayo Clinic, 200 First Street Southwest, Rochester, MN 55905, USA.
Abstract:
Prokinetic agents are medications that enhance coordinated gastrointestinal motility and transit of content in the gastrointestinal tract, mainly by amplifying and coordinating the gastrointestinal muscular contractions. In addition to dietary therapy, prokinetic therapy should be considered as a means to improve gastric emptying and symptoms of gastroparesis, balancing benefits and risks of treatment. In the United States, metoclopramide remains the first-line prokinetic therapy, because it is the only approved medication for gastroparesis. Newer agents are being developed for the management of gastroparesis. This article provides detailed information about prokinetic agents for the treatment of gastroparesis.
More Related Videos
09:29Fabrication and Implantation of Miniature Dual-element Strain Gages for Measuring In Vivo Gastrointestinal Contractions in Rodents.
Published on: September 18, 2014
06:01Author Spotlight: Reliable and Reproducible In Vitro Assessment of Drug Impact on Rat Intestinal Tubes
Published on: July 26, 2024
Related Concept Videos
Drugs Affecting GI Tract Motility: Dopamine Receptor Antagonists
Drugs Affecting GI Tract Motility: Serotonin Receptor Agonists
Gastrointestinal Motility Disorders
Gastric Motility
Peristaltic Waves and Chyme Formation
Upon food entry, the stomach initiates...
Chemotherapy-Induced Nausea and Vomiting: Neurokinin-1 Receptor Antagonists
Gastric Emptying